Literature DB >> 24059503

Predicting affinity- and specificity-enhancing mutations at protein-protein interfaces.

Oz Sharabi1, Jason Shirian, Julia M Shifman.   

Abstract

Manipulations of PPIs (protein-protein interactions) are important for many biological applications such as synthetic biology and drug design. Combinatorial methods have been traditionally used for such manipulations, failing, however, to explain the effects achieved. We developed a computational method for prediction of changes in free energy of binding due to mutation that bring about deeper understanding of the molecular forces underlying binding interactions. Our method could be used for computational scanning of binding interfaces and subsequent analysis of the interfacial sequence optimality. The computational method was validated in two biological systems. Computational saturated mutagenesis of a high-affinity complex between an enzyme AChE (acetylcholinesterase) and a snake toxin Fas (fasciculin) revealed the optimal nature of this interface with only a few predicted affinity-enhancing mutations. Binding measurements confirmed high optimality of this interface and identified a few mutations that could further improve interaction fitness. Computational interface scanning of a medium-affinity complex between TIMP-2 (tissue inhibitor of metalloproteinases-2) and MMP (matrix metalloproteinase) 14 revealed a non-optimal nature of the binding interface with multiple mutations predicted to stabilize the complex. Experimental results corroborated our computational predictions, identifying a large number of mutations that improve the binding affinity for this interaction and some mutations that enhance binding specificity. Overall, our computational protocol greatly facilitates the discovery of affinity- and specificity-enhancing mutations and thus could be applied for design of potent and highly specific inhibitors of any PPI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24059503     DOI: 10.1042/BST20130121

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  9 in total

Review 1.  Integrative systems and synthetic biology of cell-matrix adhesion sites.

Authors:  Eli Zamir
Journal:  Cell Adh Migr       Date:  2016-02-06       Impact factor: 3.405

2.  Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.

Authors:  Valeria Arkadash; Gal Yosef; Jason Shirian; Itay Cohen; Yuval Horev; Moran Grossman; Irit Sagi; Evette S Radisky; Julia M Shifman; Niv Papo
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

3.  Combinatorial and Computational Approaches to Identify Interactions of Macrophage Colony-stimulating Factor (M-CSF) and Its Receptor c-FMS.

Authors:  Lior Rosenfeld; Jason Shirian; Yuval Zur; Noam Levaot; Julia M Shifman; Niv Papo
Journal:  J Biol Chem       Date:  2015-09-10       Impact factor: 5.157

Review 4.  Computational Tools and Strategies to Develop Peptide-Based Inhibitors of Protein-Protein Interactions.

Authors:  Maxence Delaunay; Tâp Ha-Duong
Journal:  Methods Mol Biol       Date:  2022

5.  Converting a broad matrix metalloproteinase family inhibitor into a specific inhibitor of MMP-9 and MMP-14.

Authors:  Jason Shirian; Valeria Arkadash; Itay Cohen; Tamila Sapir; Evette S Radisky; Niv Papo; Julia M Shifman
Journal:  FEBS Lett       Date:  2018-03-12       Impact factor: 4.124

6.  Antibody Binding Selectivity: Alternative Sets of Antigen Residues Entail High-Affinity Recognition.

Authors:  Yves Nominé; Laurence Choulier; Gilles Travé; Thierry Vernet; Danièle Altschuh
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

7.  Affinity- and specificity-enhancing mutations are frequent in multispecific interactions between TIMP2 and MMPs.

Authors:  Oz Sharabi; Jason Shirian; Moran Grossman; Mario Lebendiker; Irit Sagi; Julia Shifman
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

8.  Combinatorial engineering of N-TIMP2 variants that selectively inhibit MMP9 and MMP14 function in the cell.

Authors:  Valeria Arkadash; Evette S Radisky; Niv Papo
Journal:  Oncotarget       Date:  2018-08-10

9.  Generating quantitative binding landscapes through fractional binding selections combined with deep sequencing and data normalization.

Authors:  Michael Heyne; Niv Papo; Julia M Shifman
Journal:  Nat Commun       Date:  2020-01-15       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.